The number of pharmaceutical suppliers who are able to deliver at least 80% of their products on time and in full (OTIF) dropped 16 percentage points from last year, according to a new white paper on the drug supply chain by global market intelligence firm IDC.Similarly, the amount of pharmaceutical companies who can deliver OTIF products to their customers at least 80% of the time dropped 17 percentage points.The white paper, titled "Supply Chain Agility in the Pharmaceutical Industry," argues that without the visibility and agility given by end-to-end approaches and data sharing, companies do not have the resilient supply chain needed in the face of the COVID-19 pandemic.